Rothschild & Co Redburn Adjusts Price Target on Pfizer to $25 From $27, Maintains Neutral Rating
Pfizer (PFE) has an average rating of overweight and mean price target of $28.68, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks